Publications
Information about journal articles, updated at 25-05-2025, from platform CIÊNCIAVITAE.
Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue Sarcoma
Ana Amaral; Carmen Salguero Aranda; Joaquín Olmedo-Pelayo; Enrique de Alava; Ana Teresa Amaral; Juan Diaz-Martin, Cancers. 6211 - 6211. 24. 14. 2022. http://dx.doi.org/10.3390/cancers14246211 . 10.3390/cancers14246211 . Cancers
Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell–Matrix Interactions
Puerto-Camacho, Pilar; Díaz-Martín, Juan; Olmedo-Pelayo, Joaquín; Bolado-Carrancio, Alfonso; Salguero-Aranda, Carmen; Jordán-Pérez, Carmen; Esteban-Medina, Marina; et al, International Journal of Molecular Sciences. 15. 23. 2022. http://dx.doi.org/10.3390/ijms23158657 . 10.3390/ijms23158657 . published International Journal of Molecular Sciences
Selective modulation by PARP-1 of HIF-1a-recruitment to chromatin during hypoxia is required for tumor adaptation to hypoxic conditions
Martí, Juan Manuel; Garcia-Diaz, Angel; Delgado-Bellido, Daniel; O'Valle, Francisco; González-Flores, Ariannys; Carlevaris, Onintza; Rodríguez-Vargas, José Manuel; et al, Redox Biology. 41. 2021. http://dx.doi.org/10.1016/j.redox.2021.101885 . 10.1016/j.redox.2021.101885 . Redox Biology
Endoglin in the Spotlight to Treat Cancer
González Muñoz, Teresa; Amaral, Ana Teresa; Puerto-Camacho, Pilar; Peinado, Héctor; de Álava, Enrique, International Journal of Molecular Sciences. 6. 22. 2021. http://dx.doi.org/10.3390/ijms22063186 . 10.3390/ijms22063186 . International Journal of Molecular Sciences
Hippo pathway effectors YAP1/TAZ induce an EWS–FLI1 -opposing gene signature and associate with disease progression in Ewing sarcoma
The Journal of Pathology. 374 - 386. 4. 250. 2020. http://dx.doi.org/10.1002/path.5379 . 10.1002/path.5379 . The Journal of Pathology
Breakthrough Technologies Reshape the Ewing Sarcoma Molecular Landscape
Cells. 804 - 804. 4. 9. 2020. http://dx.doi.org/10.3390/cells9040804 . 10.3390/cells9040804 . Cells
Preclinical Efficacy of Endoglin-Targeting Antibody–Drug Conjugates for the Treatment of Ewing Sarcoma
Clinical Cancer Research. 2228 - 2240. 7. 25. 2019. http://dx.doi.org/10.1158/1078-0432.ccr-18-0936 . 10.1158/1078-0432.ccr-18-0936 . Clinical Cancer Research
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
Nature Medicine. 386 - 395. 3. 23. 2017. http://dx.doi.org/10.1038/nm.4273 . 10.1038/nm.4273 . Nature Medicine
Ex vivo identification and characterization of a population of CD13high CD105+ CD45- mesenchymal stem cells in human bone marrow
Stem Cell Research & Therapy. 1. 6. 2015. http://dx.doi.org/10.1186/s13287-015-0152-8 . 10.1186/s13287-015-0152-8 . Stem Cell Research & Therapy
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
Oncotarget. 18875 - 18890. 22. 6. 2015. http://dx.doi.org/10.18632/oncotarget.4303 . 10.18632/oncotarget.4303 . Oncotarget
Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination with Anti-IGF Signaling Agents
Clinical Cancer Research. 1373 - 1382. 6. 21. 2015. http://dx.doi.org/10.1158/1078-0432.ccr-14-1688 . 10.1158/1078-0432.ccr-14-1688 . Clinical Cancer Research
Bone microenvironment signals in osteosarcoma development
Cellular and Molecular Life Sciences. 3097 - 3113. 16. 72. 2015. http://dx.doi.org/10.1007/s00018-015-1918-y . 10.1007/s00018-015-1918-y . Cellular and Molecular Life Sciences
Characterization of Human Mesenchymal Stem Cells from Ewing Sarcoma Patients. Pathogenetic Implications
PLoS ONE. e85814 - e85814. 2. 9. 2014. http://dx.doi.org/10.1371/journal.pone.0085814 . 10.1371/journal.pone.0085814 . PLoS ONE
Innovative Therapies in Ewing Sarcoma
Advances in Anatomic Pathology. 44 - 62. 1. 21. 2014. http://dx.doi.org/10.1097/pap.0000000000000003 . 10.1097/pap.0000000000000003 . Advances in Anatomic Pathology
IGF1R Signaling in Ewing Sarcoma Is Shaped by Clathrin-/Caveolin-Dependent Endocytosis
PLoS ONE. e19846 - e19846. 5. 6. 2011. http://dx.doi.org/10.1371/journal.pone.0019846 . 10.1371/journal.pone.0019846 . PLoS ONE
The Clinical Relevance of Molecular Genetics in Soft Tissue Sarcomas
Advances in Anatomic Pathology. 162 - 181. 3. 17. 2010. http://dx.doi.org/10.1097/pap.0b013e3181d98cbf . 10.1097/pap.0b013e3181d98cbf . Advances in Anatomic Pathology
Stable interference of EWS–FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target
British Journal of Cancer. 80 - 90. 1. 101. 2009. http://dx.doi.org/10.1038/sj.bjc.6605104 . 10.1038/sj.bjc.6605104 . British Journal of Cancer
5 17 out of 17 Publications